Page last updated: 2024-08-23

5,7-dihydroxytryptamine and Basal Ganglia Diseases

5,7-dihydroxytryptamine has been researched along with Basal Ganglia Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guerra, MJ; Labandeira-Garcia, JL; Muñoz, AM; Parga, J; Rey, P1

Other Studies

1 other study(ies) available for 5,7-dihydroxytryptamine and Basal Ganglia Diseases

ArticleYear
Glial overexpression of heme oxygenase-1: a histochemical marker for early stages of striatal damage.
    Journal of chemical neuroanatomy, 2005, Volume: 29, Issue:2

    Topics: 5,7-Dihydroxytryptamine; Afferent Pathways; Animals; Astrocytes; Basal Ganglia Diseases; Biomarkers; Corpus Striatum; Denervation; Dopamine; Female; Gliosis; Heat-Shock Proteins; Heme Oxygenase (Decyclizing); Ibotenic Acid; Immunohistochemistry; Microglia; Nerve Degeneration; Neuroglia; Neurotoxins; Oxidopamine; Oxygenases; Rats; Rats, Sprague-Dawley; Serotonin

2005
chemdatabank.com